Instil Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	0	0	0	0.14	0
Gross Profit	0	0	0	0.14	0
Selling, General & Admin	47.55	62.24	48.31	14.38	2.56
Research & Development	39.6	141.06	107.25	19.4	4.03
Other Operating Expenses	72.01	23.17	0	0	0
Operating Expenses	159.17	226.46	155.56	33.78	6.59
Operating Income	-159.17	-226.46	-155.56	-33.64	-6.59
Interest Expense / Income	5.21	1.88	0	0	0
Other Expense / Income	-8.29	-3.09	1.2	3.94	-0.06
Pretax Income	-156.09	-225.25	-156.76	-37.59	-6.52
Income Tax	0	-2.07	0.04	0.15	0
Net Income	-156.09	-223.18	-156.79	-37.74	-6.52
Shares Outstanding (Basic)	7	6	5	1	1
Shares Outstanding (Diluted)	7	6	5	1	1
Shares Change	0.44%	22.19%	562.55%	35.04%	-
EPS (Basic)	-24.00	-34.46	-29.60	-47.20	-11.00
EPS (Diluted)	-24.00	-34.46	-29.60	-47.20	-11.00
Free Cash Flow	-102.69	-264.75	-179.97	-80.43	-5.5
Free Cash Flow Per Share	-15.79	-40.88	-33.96	-100.55	-9.29
Gross Margin	-	-	-	100.00%	-
Operating Margin	-	-	-	-24379.71%	-
Profit Margin	-	-	-	-27346.38%	-
Free Cash Flow Margin	-	-	-	-58284.06%	-
EBITDA	-145.48	-215.62	-154	-37.33	-6.5
EBITDA Margin	-	-	-	-27051.45%	-
Depreciation & Amortization	5.4	7.75	2.75	0.26	0.02
EBIT	-150.88	-223.37	-156.76	-37.59	-6.52
EBIT Margin	-	-	-	-27236.96%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).